연구성과로 돌아가기
JCR 2022 저널 목록 (776 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RESEARCH QUARTERLY FOR EXERCISE AND SPORT | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | 0270-1367 | 2168-3824 | SCIE | PSYCHOLOGY | 5,204 | 2.2 | Q3 | 56.2 | 43.8 | 46/81 | 2.6 | Q3 | 2.2 | 0.4 | 0.57 | 57/92 | Q3 | 38.59 | 0.002 | 0.449 | 0.557 | Q3 | 115 | 100.0% | 14.0 | 8.8 | 115 | 4.1% | 2025-04-21 10:31:28 | 바로가기 |
| Transplantation Reviews | ELSEVIER SCIENCE INC | 0955-470X | N/A | SCIE | IMMUNOLOGY | 1,272 | 4.0 | Q3 | 56.2 | 43.8 | 91/161 | 3.8 | Q3 | 3.9 | 0.8 | 0.72 | 77/177 | Q2 | 56.78 | 0.002 | 0.379 | 1.172 | Q2 | 34 | 0.0% | 5.7 | 7.1 | 0 | 15.6% | 2025-04-21 10:04:39 | 바로가기 |
| ULTRAMICROSCOPY | ELSEVIER | 0304-3991 | 1879-2723 | SCIE | MICROSCOPY | 8,435 | 2.2 | Q3 | 56.2 | 43.8 | 5/8 | 2.4 | Q2 | 1.9 | 0.5 | 1.09 | 2/8 | Q1 | 81.25 | 0.006 | 1.316 | 0.731 | Q1 | 98 | 100.0% | 10.6 | 9.6 | 98 | 32.7% | 2025-04-21 10:17:28 | 바로가기 |
| American Journal of Cardiovascular Drugs | ADIS INT LTD | 1175-3277 | 1179-187X | SCIE | PHARMACOLOGY & PHARMACY | 1,570 | 3.0 | Q3 | 56.3 | 43.7 | 157/278 | 2.9 | Q3 | 2.9 | 0.8 | 0.64 | 181/366 | Q2 | 50.68 | 0.002 | 0.412 | 0.755 | Q2 | 39 | 61.5% | 5.3 | 4.9 | 24 | 20.1% | 2025-04-21 10:24:36 | 바로가기 |
| BLOOD PURIFICATION | KARGER | 0253-5068 | 1421-9735 | SCIE | HEMATOLOGY | 3,436 | 3.0 | Q3 | 56.3 | 43.7 | 45/79 | 2.9 | Q3 | 2.9 | 0.6 | 0.79 | 31/97 | Q2 | 68.56 | 0.004 | 0.823 | 0.728 | Q3 | 70 | 75.7% | 5.7 | 7.3 | 53 | 12.7% | 2025-04-21 10:00:59 | 바로가기 |
| CANCER CHEMOTHERAPY AND PHARMACOLOGY | SPRINGER | 0344-5704 | 1432-0843 | SCIE | PHARMACOLOGY & PHARMACY | 10,905 | 3.0 | Q3 | 56.3 | 43.7 | 157/278 | 3.1 | Q3 | 2.9 | 0.7 | 0.70 | 162/366 | Q2 | 55.87 | 0.006 | 1.349 | 0.633 | Q3 | 115 | 92.2% | 8.9 | 7.5 | 106 | 24.8% | 2025-04-21 10:24:13 | 바로가기 |
| China Foundry | SPRINGER SINGAPORE PTE LTD | 1672-6421 | 2365-9459 | SCIE | METALLURGY & METALLURGICAL ENGINEERING | 782 | 1.6 | Q3 | 56.3 | 43.7 | 45/79 | 1.4 | Q3 | 1.2 | 0.2 | 0.29 | 54/91 | Q3 | 41.21 | 0.000 | 0.107 | 0.179 | Q3 | 70 | 98.6% | 5.2 | 8.3 | 69 | 0.5% | 2025-04-21 10:16:50 | 바로가기 |
| CNS & Neurological Disorders-Drug Targets | BENTHAM SCIENCE PUBL | 1871-5273 | 1996-3181 | SCIE | PHARMACOLOGY & PHARMACY | 3,879 | 3.0 | Q3 | 56.3 | 43.7 | 157/278 | 3.2 | Q3 | 2.9 | 2.3 | 0.54 | 221/366 | Q3 | 39.75 | 0.002 | 0.367 | 0.487 | Q3 | 78 | 33.3% | 7.8 | 9.3 | 26 | 1.9% | 2025-04-21 10:24:24 | 바로가기 |
| CORROSION | NATL ASSOC CORROSION ENG | 0010-9312 | 1938-159X | SCIE | METALLURGY & METALLURGICAL ENGINEERING | 6,885 | 1.6 | Q3 | 56.3 | 43.7 | 45/79 | 1.9 | Q2 | 1.4 | 0.4 | 0.33 | 49/91 | Q3 | 46.70 | 0.002 | 0.361 | 0.321 | Q2 | 104 | 100.0% | 19.7 | 11.1 | 104 | 2.9% | 2025-04-21 10:16:45 | 바로가기 |
| DRUGS IN R&D | SPRINGER INT PUBL AG | 1174-5886 | 1179-6901 | SCIE | PHARMACOLOGY & PHARMACY | 1,290 | 3.0 | Q3 | 56.3 | 43.7 | 157/278 | 3.1 | Q3 | 3.0 | 0.8 | 0.65 | 179/366 | Q2 | 51.23 | 0.001 | 0.290 | 0.746 | Q2 | 32 | 93.8% | 6.0 | 6.2 | 30 | 100.0% | 2025-04-21 10:24:37 | 바로가기 |
| Hematology-American Society of Hematology Education Program | AMER SOC HEMATOLOGY | 1520-4391 | 1520-4383 | SCIE | HEMATOLOGY | 3,941 | 3.0 | Q3 | 56.3 | 43.7 | 45/79 | 3.7 | Q2 | 2.9 | <0.1 | 0.82 | 30/97 | Q2 | 69.59 | 0.005 | 1.090 | 1.331 | Q2 | 93 | 92.5% | 6.7 | 4.2 | 86 | 0.7% | 2025-04-21 10:00:59 | 바로가기 |
| International Journal of Laboratory Hematology | WILEY | 1751-5521 | 1751-553X | SCIE | HEMATOLOGY | 3,350 | 3.0 | Q3 | 56.3 | 43.7 | 45/79 | 2.7 | Q3 | 2.8 | 0.3 | 0.47 | 56/97 | Q3 | 42.78 | 0.004 | 0.893 | 0.636 | Q3 | 118 | 85.6% | 4.3 | 7.1 | 101 | 7.9% | 2025-04-21 10:00:59 | 바로가기 |
| International Journal of Unconventional Computing | OLD CITY PUBLISHING INC | 1548-7199 | 1548-7202 | SCIE | COMPUTER SCIENCE, THEORY & METHODS | 182 | 1.7 | Q3 | 56.3 | 43.7 | 63/111 | 1.2 | Q3 | 1.5 | 0.2 | 0.38 | 90/145 | Q3 | 38.28 | 0.000 | 0.049 | 0.319 | Q4 | 14 | 100.0% | 4.7 | 9.1 | 14 | 0.0% | 2025-04-21 09:43:08 | 바로가기 |
| JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | LIPPINCOTT WILLIAMS & WILKINS | 0160-2446 | 1533-4023 | SCIE | PHARMACOLOGY & PHARMACY | 6,333 | 3.0 | Q3 | 56.3 | 43.7 | 157/278 | 3.0 | Q3 | 2.9 | 0.8 | 0.71 | 158/366 | Q2 | 56.97 | 0.003 | 0.648 | 0.541 | Q3 | 186 | 73.1% | 10.6 | 6.9 | 136 | 12.4% | 2025-04-21 10:24:19 | 바로가기 |
| JOURNAL OF CHEMOMETRICS | WILEY | 0886-9383 | 1099-128X | SCIE | INSTRUMENTS & INSTRUMENTATION | 4,269 | 2.4 | Q3 | 56.3 | 43.7 | 36/63 | 2.3 | Q3 | 2.2 | 0.4 | 0.64 | 31/76 | Q2 | 59.87 | 0.002 | 0.332 | 0.414 | Q3 | 56 | 96.4% | 13.9 | 7.9 | 54 | 20.8% | 2025-04-21 10:05:33 | 바로가기 |
페이지 이동: